MRI | Active surveillance

Location: Plenary 3

Back to list

Overview

Critical Role of Pathology for Active Surveillance Criteria & Definition of “Progression”

Time:
1:30 PM - 1:50 PM
Speakers:

Dr Jonathan Epstein

Evidence gathering. PROMIS and beyond. Exploring the next set of trials we might wish to do

Time:
1:50 PM - 2:10 PM
Speakers:

Dr Mark Emberton

What should we do with PIRADS 3 lesions?

Time:
2:10 PM - 2:30 PM
Speakers:

Dr Ben Challacombe

Challenges in Implementing Active Surveillance for Prostate Cancer

Time:
2:30 PM - 2:45 PM
Speakers:

Dr William Catalona

Discussion

Time:
2:45 PM - 3:00 PM
Speakers:

Panel Discussion